Skip to content
Clinical Trials – home
CroatiaBack to Croatia

Clinical trials in Rijeka

91 clinical trials in Rijeka, Croatia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

CroatiaOur site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Rijeka at a glance
91
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

91 trials in Rijeka

Open in trial search
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.
Countries:CroatiaCroatia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:XMAB942
  • Sponsor:Xencor Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Apremilast
  • Sponsor:Takeda Development Center Americas Inc.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.
Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Bhv-7000
  • Sponsor:Biohaven Therapeutics Ltd.

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Rijeka

What the registry says about research in the country

01 Inflammatory Conditions

Research focused on treating various inflammatory diseases, including Psoriatic Arthritis, Crohn's Disease, and Ulcerative Colitis. Clinical trials are evaluating novel therapies to improve patient outcomes.

  • Psoriatic Arthritis Studies
  • Inflammatory Bowel Disease Research
  • Autoimmune Disease Treatments

Multiple innovative treatments are being tested to address inflammation and improve quality of life.

02 Oncology Research

Groundbreaking studies in cancer treatment, particularly focusing on Non-Small Cell Lung Cancer and Acute Myeloid Leukemia. New therapeutic approaches are being evaluated to enhance treatment efficacy.

  • Advanced Cancer Therapies
  • Blood Cancer Treatment
  • Combination Therapy Studies

These trials aim to develop more effective treatments for various types of cancer.

03 Neurological Disorders

Comprehensive research into neurological conditions, including Multiple Sclerosis and Epilepsy. Studies are investigating new therapeutic options for better disease management.

  • MS Treatment Innovation
  • Seizure Control Studies
  • Neurological Disease Management

Trials focus on improving symptoms and developing more effective treatment approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).